Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
64,19 USD | +2,18% | +5,68% | +16,41% |
24/06 | Top stijgers in de middag | MT |
24/06 | Sectorupdate: Gezondheidszorgaandelen stijgen maandag premarket | MT |
Vakgebied
Aantal werknemers: 642
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Generics, Established Brands, and Other
77,0
%
| 275 | 86,8 % | 375 | 77,0 % | +36,40% |
Rare Disease
23,0
%
| 42 | 13,2 % | 112 | 23,0 % | +168,95% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
99,9
%
| 312 | 98,7 % | 486 | 99,9 % | +55,64% |
Canada
0,1
%
| 4 | 1,3 % | 1 | 0,1 % | -85,73% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 08-09-20 |
Stephen Carey
DFI | Director of Finance/CFO | 53 | 06-05-16 |
Patrick Walsh
CHM | Chairman | 63 | 17-05-18 |
Elizabeth Powell
CMP | Compliance Officer | - | 24-02-22 |
Mary Pao
CTO | Chief Tech/Sci/R&D Officer | - | 24-02-22 |
Chief Tech/Sci/R&D Officer | 56 | 19-11-21 | |
James Marken
COO | Chief Operating Officer | 61 | 01-03-07 |
Krista Davis
HRO | Human Resources Officer | 51 | 12-09-22 |
Meredith Cook
LAW | General Counsel | 50 | 18-07-22 |
Ori Gutwerg
PRN | Corporate Officer/Principal | 50 | 01-02-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Haughey
BRD | Director/Board Member | 60 | 01-05-18 |
Antonio Pera
BRD | Director/Board Member | 66 | 06-08-20 |
Patrick Walsh
CHM | Chairman | 63 | 17-05-18 |
Renee Tannenbaum
BRD | Director/Board Member | 72 | 22-03-22 |
Jeanne A. Thoma
BRD | Director/Board Member | 64 | 06-08-20 |
Chief Tech/Sci/R&D Officer | 56 | 19-11-21 | |
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 08-09-20 |
Matthew Leonard
BRD | Director/Board Member | 58 | 21-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 10 864 | 0 | 0 | 80,44 % |
Aandeel B | 1 | 21 354 608 | 17 185 701 ( 80,48 %) | 392 959 ( 1,840 %) | |
Aandeel C | 0 | 25 000 | 0 | 0 |
Bedrijfsgegevens
ANI Pharmaceuticals, Inc.
210 Main Street West
56623, Baudette
+218 634 3500
http://www.anipharmaceuticals.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,41% | 1,22 mld. | |
+55,19% | 801 mld. | |
+47,26% | 631 mld. | |
-6,09% | 359 mld. | |
+21,92% | 337 mld. | |
+18,40% | 245 mld. | |
+3,64% | 231 mld. | |
+12,98% | 219 mld. | |
+10,86% | 171 mld. | |
-2,78% | 161 mld. |
- Beurs
- Aandelen
- Koers ANIP
- Onderneming ANI Pharmaceuticals, Inc.